| 517.1 | V08AB02 | iohexol (koncentrace 180 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 243,27 | K |
| 87801 | OMNIPAQUE 180 | inj 10x10ml | NYI | N |
| 87802 | OMNIPAQUE 180 | inj 10x15ml | NYI | N |
| 517.2 | V08AB02 | iohexol (koncentrace 240 mg l/ml, od 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 209,89 | K |
| 04337 | OMNIPAQUE 240 | inj 25x20ml | NYI | N |
| 87602 | OMNIPAQUE 240 | inj 6x20ml | NYI | N |
| 517.3 | V08AB02 | iohexol (koncentrace 240 mg l/ml, do 15 ml v jedné ampuli včetně) | parent. | 10 | ML | 290,63 | K |
| 94219 | OMNIPAQUE 240 | inj 10x10ml | NYI | N |
| 517.4 | V08AB02 | iohexol (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 161,45 | K |
| 04338 | OMNIPAQUE 240 | inj 10x50ml | NYI | N |
| 04339 | OMNIPAQUE 240 | inj 6x200ml | NYI | N |
| 517.5 | V08AB02 | iohexol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 244,00 | K |
| 04328 | OMNIPAQUE 300 | inj 6x20ml | NYI | N |
| 04329 | OMNIPAQUE 300 | inj 25x20ml | NYI | N |
| 517.6 | V08AB02 | iohexol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 337,85 | K |
| 94220 | OMNIPAQUE 300 | inj 10x10ml | NYI | N |
| 517.7 | V08AB02 | iohexol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 187,70 | K |
| 04330 | OMNIPAQUE 300 | inj 10x50ml (sklo) | NYI | N |
| 62466 | OMNIPAQUE 300 | inj 10x50ml (pp) | NYI | N |
| 87600 | OMNIPAQUE 300 | inj 10x100ml | NYI | N |
| 517.8 | V08AB02 | iohexol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 272,60 | K |
| 04332 | OMNIPAQUE 350 | inj 6x20ml | NYI | N |
| 04333 | OMNIPAQUE 350 | inj 25x20ml | NYI | N |
| 517.9 | V08AB02 | iohexol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 206,69 | K |
| 87603 | OMNIPAQUE 350 | inj 10x50ml (sklo) | NYI | N |
| 62467 | OMNIPAQUE 350 | inj 10x50ml (pp) | NYI | N |
| 04335 | OMNIPAQUE 350 | inj 10x100ml | NYI | N |
| 75261 | OMNIPAQUE 350 | inj 6x200ml | NYI | N |
| 517.10 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 249,38 | K |
| 88645 | HEXABRIX 320(HEXABRIX 85) | inj 20ml | BGL | D |
| 517.11 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 196,74 | K |
| 517.12 | V08AB04 | iopamidol (koncentrace 200 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 255,30 | K |
| 71989 | IOPAMIRO 200 | inj 5x10ml | BCC | I |
| 88657 | IOPAMIRO 200 | inj 1x30ml | BCC | I |
| 517.13 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 315,56 | K |
| 71993 | IOPAMIRO 300 | inj 5x10ml | BCC | I |
| 88654 | IOPAMIRO 300 | inj 1x10ml | BCC | I |
| 517.14 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 195,71 | K |
| 88655 | IOPAMIRO 300 | inj 1x30ml | BCC | I |
| 517.15 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 178,60 | K |
| 71994 | IOPAMIRO 300 | inj 1x100ml | BCC | I |
| 88656 | IOPAMIRO 300 | inj 1x50ml | BCC | I |
| 517.16 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 385,26 | K |
| 88658 | IOPAMIRO 370 | inj 1x10ml | BCC | I |
| 517.17 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, nad 15 do 30 ml v jedné ampuli včetně) | parent. | 10 | ML | 236,77 | K |
| 88659 | IOPAMIRO 370 | inj 1x30ml | BCC | I |
| 517.18 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 190,63 | K |
| 71998 | IOPAMIRO 370 | inj 1x100ml | BCC | I |
| 88660 | IOPAMIRO 370 | inj 1x50ml | BCC | I |
| 517.19 | V08AB05 | iopromid (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 161,45 | K |
| 77015 | ULTRAVIST-240 | inj 10x50ml | SAG | D |
| 517.20 | V08AB05 | iopromid (koncentrace 300 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 244,00 | K |
| 77024 | ULTRAVIST-300 | inj 10x20ml | SAG | D |
| 517.21 | V08AB05 | iopromid (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 187,70 | K |
| 77017 | ULTRAVIST-300 | inj 10x100ml | SAG | D |
| 77016 | ULTRAVIST-300 | inj 10x50ml | SAG | D |
| 93627 | ULTRAVIST-300 | inj 1x50ml | SAG | D |
| 93628 | ULTRAVIST-300 | inj 1x100ml | SAG | D |
| 517.22 | V08AB05 | iopromid (koncentrace 370 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 218,29 | K |
| 77019 | ULTRAVIST-370 | inj 10x100ml | SAG | D |
| 77018 | ULTRAVIST-370 | inj 10x50ml | SAG | D |
| 93625 | ULTRAVIST-370 | inj 1x100ml | SAG | D |
| 517.23 | V08AB06 | iotrolan (koncentrace 240 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 452,33 | K/P |
| 96349 | ISOVIST 240 | inj 1x10ml 240mg/ml | SAG | D |
| 517.24 | V08AB06 | iotrolan (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 562,40 | K/P |
| 96351 | ISOVIST 300 | inj 1x10ml 300mg/ml | SAG | D |
| 517.25 | V08AB07 | ioversol (koncentrace 160 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 125,77 | K |
| 68772 | OPTIRAY 160 | inj 10x50ml | MME | D |
| 517.26 | V08AB07 | ioversol (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 161,45 | K |
| 68922 | OPTIRAY 240 | inj 10x100ml | MME | D |
| 98298 | OPTIRAY 240 | inj 10x50ml | MME | D |
| 517.27 | V08AB07 | ioversol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 337,85 | K |
| 92365 | OPTIRAY 300 | inj 10x10ml | MME | D |
| 517.28 | V08AB07 | ioversol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 244,00 | K |
| 68923 | OPTIRAY 300 | inj 10x20ml | MME | D |
| 517.29 | V08AB07 | ioversol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 187,70 | K |
| 68850 | OPTIRAY 300 | inj 10x50ml | MME | D |
| 92366 | OPTIRAY 300 | inj 10x75ml | MME | D |
| 92368 | OPTIRAY 300 | inj 10x150ml | MME | D |
| 92369 | OPTIRAY 300 | inj 10x200ml | MME | D |
| 92367 | OPTIRAY 300 | inj 10x100ml | MME | D |
| 517.30 | V08AB07 | ioversol (koncentrace 320 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 196,74 | K |
| 68773 | OPTIRAY 320 | inj 10x50ml | MME | D |
| 517.31 | V08AB07 | ioversol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 272,60 | K |
| 92370 | OPTIRAY 350 | inj 10x30ml | MME | D |
| 517.32 | V08AB07 | ioversol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 209,69 | K |
| 68925 | OPTIRAY 350 | inj 10x100ml | MME | D |
| 92371 | OPTIRAY 350 | inj 10x200ml | MME | D |
| 68851 | OPTIRAY 350 | inj 10x50ml | MME | D |
| 517.33 | V08AB10 | iomeprol (koncentrace 150 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 122,00 | K |
| 517.34 | V08AB10 | iomeprol (koncentrace 200 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 144,34 | K |
| 517.35 | V08AB10 | iomeprol (koncentrace 250 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 165,75 | K |
| 517.36 | V08AB10 | iomeprol (koncentrace 300 mg l/ml, do 30 ml v ampuli) | parent. | 10 | ML | 244,00 | K |
| 517.37 | V08AB10 | iomeprol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 187,70 | K |
| 517.38 | V08AB10 | iomeprol (koncentrace 350 mg l/ml, do 30 ml v ampuli) | parent. | 10 | ML | 272,60 | K |
| 517.39 | V08AB10 | iomeprol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 209,69 | K |
| 517.40 | V08AB10 | iomeprol (koncentrace 400 mg l/ml, do 30 ml v ampuli) | parent. | 10 | ML | 300,90 | K |
| 517.41 | V08AB10 | iomeprol (koncentrace 400 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 231,44 | K |
| 517.42 | V08AB09 | iodixanol (koncentrace 150mgl/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 226,80 | K/P |
| 84340 | VISIPAQUE 150MG l/ML | inj 6x200ml | NYI | N |
| 84339 | VISIPAQUE 150MG l/ML | inj 10x50ml | NYI | N |
| 45114 | VISIPAQUE 150MG l/ML | inj 10x50ml | NRI | IRL |
| 45115 | VISIPAQUE 150MG l/ML | inj 6x200ml | NRI | IRL |
| 517.43 | V08AB09 | iodixanol (koncentrace 270mgl/ml, do 30 ml včetně v jedné ampuli ) | parent. | 10 | ML | 354,32 | K/P |
| 84341 | VISIPAQUE 270MG l/ML | inj 10x20ml | NYI | N |
| 45118 | VISIPAQUE 270MG l/ML | inj 10x20ml | NRI | IRL |
| 517.44 | V08AB09 | iodixanol (koncentrace 270mgl/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 296,99 | K |
| 84342 | VISIPAQUE 270MG l/ML | inj 10x50ml | NYI | N |
| 84343 | VISIPAQUE 270MG l/ML | inj 10x100ml | NYI | N |
| 84344 | VISIPAQUE 270MG l/ML | inj 6x200ml | NYI | N |
| 45121 | VISIPAQUE 270MG l/ML | inj 6x200ml | NRI | IRL |
| 45119 | VISIPAQUE 270MG l/ML | inj 10x50ml | NRI | IRL |
| 517.45 | V08AB09 | iodixanol (koncentrace 320mgl/ml, do 30 ml včetně v jedné ampuli) | parent. | 10 | ML | 376,27 | K/P |
| 84345 | VISIPAQUE 320MG l/ML | inj 10x20ml | NYI | N |
| 45122 | VISIPAQUE 320MG l/ML | inj 10x20ml | NRI | IRL |
| 517.46 | V08AB09 | iodixanol (koncentrace 320mgl/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 302,37 | K |
| 84346 | VISIPAQUE 320MG l/ML | inj 10x50ml | NYI | N |
| 84347 | VISIPAQUE 320MG l/ML | inj 10x100ml | NYI | N |
| 84348 | VISIPAQUE 320MG l/ML | inj 6x200ml | NYI | N |
| 45123 | VISIPAQUE 320MG l/ML | inj 10x50ml | NRI | IRL |
| 45125 | VISIPAQUE 320MG l/ML | inj 10x200ml | NRI | IRL |
| 45124 | VISIPAQUE 320MG l/ML | inj 10x100ml | NRI | IRL |
| 518 | V08AC | rozpustné hepatotropní RTG kontrastní látky | parent. | K |
| 518.1 | V08AC | kyselina iodoxamová (koncentrace 183 mg l/ml) | parent. | 10 | ML | 75,25 | K |
| 518.2 | V08AC | kyselina iodoxamová (koncentrace 45 mg l/ml) | parent. | 10 | ML | 37,39 | K |
| 518.3 | V08AC04 | adipiodon | parent. | 10 | ML | 39,35 | K |
| 519 | V08AD | nerozpustné RTG kontrastní látky | parent. | K |
| 519.1 | V08AD | iopydol + iopyron | parent. | 10 | ML | 300,70 | K |
| 519.2 | V08AD01 | ethylestery jodovaných mastných kyselin | parent. | 10 | ML | 462,54 | K |
| 03552 | LIPIODOL ULTRA-FLUID | inj 5x5ml | BGL | D |
| 520 | V08BA | RTG kontrastní přípravky obsahující síran barnatý | p.o. | K |
| 520.1 | V08BA | síran barnatý | p.o. | 100 | GM | 33,29 | K |
| 06303 | MICROPAQUE CT | sus 1x2000ml | GUE | D |
| 94370 | PRONTOBARIO 60% | sus 1x5lt | BCC | I |
| 520.2 | V08BA01 | síran barnatý (lékové formy pro CT) | p.o. | 7.5 | GM | 154,12 | K |
| 44367 | MICROPAQUE CT | sus 1x2000ml/ 100gm | GUE | D |
| 46675 | MICROPAQUE CT | sus 1x2000ml/ 100gm | DEF | F |
| 520.3 | V08BA01 | síran barnatý (lékové formy kolon) | p.o. | 100 | GM | 45,75 | K |
| 91066 | MICROPAQUE COLON | plv 1x800gm | GUE | D |
| 520.4 | V08BA01 | síran barnatý (lékové formy pasty) | p.o. | 100 | GM | 94,58 | K |
| 62535 | PRONTOBARIO ESOFAGO | sus 6x250ml (tuba) | BCC | I |
| 520.5 | V08BA01 | síran barnatý (lékové formy HD) | p.o. | 100 | GM | 38,08 | K |
| 56578 | PRONTOBARIO HD | plv 24x340gm | BCC | I |
| 06304 | MICROPAQUE H.D. ORAL | plv 1x416gm | GUE | D |
| 521 | V08CA | paramagnetické kontrastní látky | parent. | K |
| 521.1 | V08CA01 | dimeglumin gadopentetat (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K |
| 75660 | MAGNEVIST | inj 1x10ml | SAG | D |
| 75659 | MAGNEVIST | inj 1x5ml | SAG | D |
| 521.2 | V08CA01 | dimeglumin gadopentetat (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K |
| 96352 | MAGNEVIST | inj 1x20ml | SAG | D |
| 521.3 | V08CA03 | gadodiamid (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K |
| 55822 | OMNISCAN 0.5MMOL/ML | inj 10x5ml | NYI | N |
| 78815 | OMNISCAN 0.5MMOL/ML | inj 10x10ml | NYI | N |
| 521.4 | V08CA03 | gadodiamid (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K |
| 78816 | OMNISCAN 0.5MMOL/ML | inj 10x15ml | NYI | N |
| 78817 | OMNISCAN 0.5MMOL/ML | inj 10x20ml | NYI | N |
| 521.5 | V08DA02 | mikročástice galgaktózy | parent. | 1 | GM | 1142,99 | H |